The Effect of Selective Endothelin Receptor a Antagonism by Bq-123 on Myocardial Ischemia-Reperfusion Induced Apoptotic Cell Death

The objective of the present study was to investigate the possible impact of specific endothelin-A (ETA) receptor blockage by BQ-123 on myocardial ischemia-reperfusion (MI/R) induced apoptosis in rats. To produce MI/R, a branch of the descending left coronary artery was occluded for 30 min followed by 2 h reperfusion. Thirty-two rats were randomly assigned to four groups equally: (1) sham-operated group, (2) MI/R group, (3) MI/R+BQ-123-treated group, and (4) MI/R+ET-1+BQ-123-treated group. TUNEL staining, caspase-3 and caspase-9 activities were determined immunohistologically. MI/R group revealed extensive TUNEL positive cardiomyocytes especially in the free wall of the left ventricule, interventicular septum, and apex zone. Intensity of TUNEL-positive cardiomyocytes reduced as a result of BQ-123 treatment compared to the sham group in the same sections. Result of the caspase activity was found to correlate with TUNEL evaluation. BQ-123 administrations to MI/R group with or without ET-1 caused significant decrease both in lipid peroxidation and nitric oxide (NO) generation. Also, BQ-123 leads to augmentation of superoxide dismutase, catalase and glutathione contents. We propose that selective ETA antagonism by BQ-123 has a worthwhile effect on apoptotic cell death following MI/R, and that scavenging of free radicals by selective ETA antagonist is part of this beneficial effect.

Anahtar Kelimeler:

-

The Effect of Selective Endothelin Receptor a Antagonism by Bq-123 on Myocardial Ischemia-Reperfusion Induced Apoptotic Cell Death

Keywords:

Apoptosis, ETA receptor antagonist (BQ-123), endothelin, NO, reactive oxygen radicals rat,

PDF

___

Abbate A, Bussani R, Amin MS, Vetrovec GW, Baldi A. Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol 2006;38(11):1834-40
Abbate A, De Falco M, Morales C, Gelpi RJ, Prisco M, De Luca A et al. Electron microscopy characterization of cardiomyocyte apoptosis in ischemic heart disease. Int J Cardiol 2007;114(1):118-20.
Eitel I, Nowak M, Stehl C, Adams V, Fuernau G, Hildebrand L et al. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no- reflow assessed by contrast-enhanced magnetic resonance imaging. Am Heart J 2010;159(5):882-90.
Lecour S, Maupoil V, Zeller M, Laubriet A, Briot T, Rochette L. Levels of nitric oxide in the heart after experimental myocardial ischemia. J Cardiovasc Pharmacol 2001;37(1):55-63.
Mehta JL, Nichols WW, Donnelly WH, Lawson DL, Saldeen TG. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion- reperfusion. Circ Res 1989;64(1):43–54.
Kukielka GL, Hawkins HK, Michael L, Manning AM, Youker K, Lane C et al. Regulation of intercellular adhesion
molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 1993;92(3):1504-16.
Lam HC, Takahashi K, Ghatei MA, Warrens AN, Rees AJ, Bloom SR. Immunoreactive endothelin in human plasma, urine, milk, and saliva. J Cardiovasc Pharmacol 1991;17:S390-93.
Ozdemir R, Parlakpinar H, Polat A, Colak C, Ermis N, Acet A. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Toxicology 2006; 219(1-3):142-49.
Thiagarajan RR, Winn RK, Harlan JM. The role of leukocyte and endothelial adhesion molecules in ischemiareperfusion injury. Thromb Haemost 1997;78(1):310-4.
Coker SJ, Parratt JR, Ledingham IM, Zeitlin IJ. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 1981;291(5813):323-4.
Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005;280(13):12944-55.
Kurzelewski M, Czarnowska E, Beresewicz A. Endothelin in the mechanism of endothelial injury and neutrophil adhesion in the post-ischemic guinea-pig heart. Eur J Pharmacol 2002;434(1-2):95-107.
Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46(3):325-415.
Gupta SK, Saxena A, Singh U, Arya DS. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion. Mol Cell Biochem 2005;275(1-2):67-4.
Pernow J, Wang QD. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 1997;33(3):518–26.
Valentin JP, Gardner DG, Wiedemann E, Humphreys MH. Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic peptide. Hypertension 1991;17(6 Pt 2):864–9.
Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia infarction, and reperfusion. Cardiovasc Res 1988; 22(7):447-55.
Parlakpinar H, Sahna E, Acet A, Mizrak B, Polat A. Protective effect of caffeic acid phenethyl ester (CAPE) on myocardial ischemia–reperfusion-induced apoptotic cell death. Toxicology 2005; 209(1):1-14.
Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284(5756):555-6.
Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36(8 Pt 1):1440-3.
Aebi H. Catalase. In: Bergmeyer U, eds. Methods of Enzymatic Analysis. New York: Academic Press, 1974.
Goering PL, Morgan DL, Ali SF. Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal. J Appl Toxicol 2002;22(3):167-72.
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82(1):70-7.
Parlakpinar H, Olmez E, Acet A, Ozturk F, Tasdemir S, Ates B et al. Beneficial effects of apricot-feeding on myocardial ischemia-reperfusion injury in rats. Food Chem Toxicol 2009;47(4):802-8.
Webster KA. Programmed death as a therapeutic target to reduce myocardial infarction. Trends Pharmacol Sci 2007;28(9):492-99.
Stewart AG, Phan LH, Grigoriadis G. Physiological and pathophysiological roles of nitric oxide. Microsurgery 1994;15(10):693-702.
Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001;30(5):463-88.
Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, Qureshi IZ et al. Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol 2008;294(3):H1398–406.
Bulkley GB. Free radical-mediated reperfusion injury: a selective review. Br J Cancer Suppl 1987;8:66-73.
Saitoh S, Matsumoto K, Kamioka M, Ohkawara H, Kaneshiro T, Ishibashi T, Maruyama Y. Novel pathway of endothelin-1 and reactive oxygen species in coronary vasospasm with endothelial dysfunction. Coron Artery Dis 2009;20(6):400-08.
Ceconi C, Cargnoni A, Pasini E, Condorelli E, Curello S, Ferrari R. Evaluation of phospholipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol 1991; 260(4 Pt 2):H1057-61.
Bhagat K. Endothelial function and myocardial infarction. Cardiovasc Res 1998; 39(2):312-7.
Garjani A, Wainwright CL, Zeitlin IJ, Wilson C, Slee SJ. Effects of endothelin-1 and the ET-A receptor antagonist, BQ-123, on ischemic arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 1995;25(4):634-42.
Grover GJ, Dzwonczyk S, Parham CS. The endothelin- 1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993; 27(9):1613-8.
Pessanha MG, Mandarim-de-Lacerda CA. Influence of the chronic nitric oxide synthesis inhibition on cardiomyocytes number. Virchows Arch 2000;437(6):667-674.
Mallat Z, Fornes P, Costagliola R, Esposito B, Belmin J, Lecomte D, Tedgui A. Age and gender effects on cardiomyocyte apoptosis in the normal human heart. J Gerontol A Biol Sci Med Sci 2001; 56 (11):719-23.
Aigner T. Apoptosis, necrosis, or whatever: how to find out what really happens? J Pathol 2002; 198(1):1-4.
Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, Possati G, Gaudino M. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 2004; 25(3):304-11.
Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 1999; 99(21):2757-64.
Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60(7):1407-26.
Elsasser A, Suzuki K, Lorenz-Meyer S, Bode C, Schaper J. The role of apoptosis in myocardial ischemia: a critical appraisal. Basic Res Cardiol 2001; 96(3):219-26.
Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med 2003; 142(5):288-97.
Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 2009; 1787(11):1395-401.
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357(11):1121-35.